This slide deck developed by Shaji Kumar, Mayo Clinic Cancer Center, features evidence-based advise regarding new developments in sequential treatment and clinical findings, evaluate strategies to manage and monitor adverse events, and initiating therapy for patients with relapsed/refractory Multiple Myeloma, and much more! 

This slide deck developed by Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA features evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, and managing adverse events. 

This slide deck developed by Anne Chiang, MD, PhD, Yale School of Medicine, features evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! 

This slide deck developed by Lipika Goyle, MD, Massachusetts General Hospital, will feature expert insights on emerging therapeutic treatments, recent discoveries on novel therapies, managing strategies for monitoring and managing adverse events, and much more! 

This slide deck, developed by Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, reviews case-studys and strategies to tailor treatment to patients with Non-Hodgkin Lymphoma.

This slide deck developed by Steven H. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, reviews  guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity! 

In the second part of this two-part series, this slide deck developed by Corey S. Cutler, MD, MPH, FRCPC, shares insights on prophylactic strategies for patients undergoing a transplant at high risk for graft-versus-host disease (GVHD) and emerging data and guideline recommendations in individualized treatment plans for patients with acute and chronic GVHD.

This slide deck, developed by Hashem B. El-Serag, MD, MPH, Professor of Medicine, Baylor College of Medicine Medical Center, reviews advanced HCC treatment and supportive care considerations in the first-line, second-line, and salvage therapy settings.

This slide deck, developed by Ulka N. Vaishampayan, MD, Professor of Oncology, Wayne State University, highlights evidence-based management of nonmetastatic and metastatic castration-resistant prostate cancer.

This slide deck, developed by Oliver Sartor, MD, Medical Director, Tulane Cancer Center, provides an overview recent treatment and supportive care advances in metastatic hormone-sensitive prostate cancer.

This slide deck, developed by Beth Faiman, PhD, MSN, APN-BC, AOCN^®, Nurse Practitioner, Department of Hematologic Oncology, Cleveland Clinic Taussig Cancer Institute, reviews nursing management strategies to optimize the treatment outcomes of patients with newly diagnosed and relapsed/refractory multiple myeloma.

This slide deck, developed by Jamie E. Chaft, MD, Assistant Attending Physician, Memorial Sloan Kettering Cancer Center, reviews molecular and clinical factors that can refine personalized care plans for patients with advanced NSCLC without driver mutations. The application of emerging data in treatment planning is highlighted.

This slide deck, developed by Tanios S. Bekaii-Saab, MD, Professor of Medicine, Mayo Clinic Cancer Center, reviews recent clinical trials on the management of newly diagnosed and relapsed/refractory metastatic colorectal cancer and strategies to tailor treatment to individual patients.